Many new iron preparations have been and are being introduced on the market for the treatment of anaemia. Each of these is accompanied by the support of intensive advertising. Under these circumstances there is a danger of confusion as to the true value of these compounds. In order to obtain a clear picture of the situation one must look at the published work of the past.
In 1936 Witts published his paper on the therapeutic action of iron in which was embodied all the recent work of that time (Heath, I933; Fullerton, 1934; Witts, I93'; 1933 Table I and it can be seen that when identical doses of elemental iron are used there is no appreciable difference in the rate of haemoglobin regeneration.
However, the commercial race continues and now attention has turned from the organic compounds of iron to the chelated compounds. This is despite the original papers on the action of an iron chelate, ferric sodium ethylene-diamine tetra-acetic acid, in iron deficiency anaemia, where it was clearly shown that there was no greater absorption of iron with it than with similar doses of ferrous sulphate (Seeberg et al., I954; Will and Vilter, 1954) .
This year Franklin et al. (I958), published results using the chelated compound, iron choline citrate, and the results are almost exactly the same as with all other recognised compounds.
To turn from consideration of the various oral iron compounds to the practical problem of iron deficiency of the present day, it seems that severe iron deficiency is becoming rarer. Furthermore it is being emphasised in recent years that iron deficiency is rarely ' idiopathic' and that it is usually the result of occult bleeding recently or in the past. However, iron deficiency anaemia remains predominantly a disease of women during their reproductive life, and it is in the attendance at a maternity hospital or antenatal clinic that cases of iron deficiency will be found in the greatest numbers. Figure i shows 9.0-9.9 7.0-7.9 8.o-8.9 9.0-9. OVERI,RST 1LtJPAYS. a1~F
IG. 4. and they all concluded that this preparation produces results comparable to those found with ' ferrivenin,' though the initial effect may be somewhat slower. It seems generally accepted that intramuscular iron should be used in place of intravenous iron because of greater convenience in administration and a reduction in the tendency to reactions. Nevertheless at the Rotunda we have tended to revert to the use of ferrivenin because it was found that imferon was sometimes unsatisfactorily slow and we disliked the staining of the tissues. Figure 3 shows the results in two similar groups of cases treated with ferrivin and imferon respectively. It can be seen that there is little difference in response rate except that imferon is somewhat slower in its effect. It seemed that a more rapid response with imferon would be obtained by using this preparation intravenously. Also one should require fewer injections as imferon is two and a half times more concentrated form of iron than ferrivenin. Figure 4 shows the results of a trial in nonpregnant cases where, ferrivenin, imferon intramuscularly, and imferon intravenously are compared. Note that the time saved in using parenteral iron instead of oral iron is only two to three weeks. The interrupted line in Figure 4 indicates a rise in haemoglobin at the rate of i per cent. daily, which is the usual response to be expected with oral iron. There is no great difference in response between the different parenteral methods and the only advantage might be in the fewer injections required withimferon intravenously. However, in view of the increased likelihood of reactions with intravenous injections it seems that imferon intramuscularly will remain the parenteral treatment of choice. On the other hand reactions to intravenous iron therapy are very rare, when care is taken in administration, and when this mode of treatment is used only in cases of marked iron deficiency.
Conclusion
The newer oral iron compounds have little or no advantage over the cheaper ferrous sulphate as regards haematological response in iron deficiency anaemia. They are often better tolerated and this is of particular value in pregnancy. Psychological factors may be important in producing nausea and vomiting.
The indications for giving iron by injection are limited but it is particularly valuable for severe iron deficiency in late pregnancy when there is troublesome intolerance to oral iron. ADDENDUM Since this article was submitted for publication two important contributions to this subject have been published by Kerr and Davidson (I958) . They have found no difference between ferrous sulphate and ferrous gluconate, as regards gastrointestinal side-effects, in a most carefully controlled trial. They conclude from their studies that intolerance to oral iron preparations is ' mainly psychological in origin.' Their observations were made in pregnant women with initial haemoglobins of 10.4 g. per iOO ml. or above, and in a series of 93 nurses with initial haemoglobins ranging from 11.7 to I5.5 g. per iOO ml. These cases were suffering from only mild degrees of anaemia and intolerance to oral iron appears more common in severe degrees of anaemia with which the present paper is largely concerned. Varicose communicating veins passing into the superficial femoral vein through Hunter's canal are described. They are often missed in diagnosing varicose veins, and are a cause of persistent varices after operation. They contribute to eczema and ulceration at the ankle. The diagnosis and treatment are detailed.
